PURPOSE: To have an initial assessment of the Vero Dynamic Tracking workflow in clinical circumstances and quantify the performance of the tracking system, a simulation study was set up on 5 lung and liver patients. METHODS AND MATERIALS: The preparatory steps of a tumor tracking treatment, based on fiducial markers implanted in the tumor, were executed allowing pursuit of the tumor with the gimbaled linac and monitoring X-rays acquisition, however, without activating the 6 MV beam. Data were acquired on workflow time-efficiency, tracking accuracy and imaging exposure. RESULTS: The average time between the patient entering the treatment room and the first treatment field was about 9 min. The time for building the correlation model was 3.2 min. Tracking errors of 0.55 and 0.95 mm (1σ) were observed in PAN/TILT direction and a 2D range of 3.08 mm. A skin dose was determined of 0.08 mGy/image, with a source-to-skin distance of 900 mm and kV exposure of 1 mAs. On average 1.8 mGy/min kV skin dose was observed for 1 Hz monitoring. CONCLUSION: The Vero tracking solution proved to be fully functional and showed performance comparable with other real-time tracking systems.
PURPOSE: To have an initial assessment of the Vero Dynamic Tracking workflow in clinical circumstances and quantify the performance of the tracking system, a simulation study was set up on 5 lung and liver patients. METHODS AND MATERIALS: The preparatory steps of a tumor tracking treatment, based on fiducial markers implanted in the tumor, were executed allowing pursuit of the tumor with the gimbaled linac and monitoring X-rays acquisition, however, without activating the 6 MV beam. Data were acquired on workflow time-efficiency, tracking accuracy and imaging exposure. RESULTS: The average time between the patient entering the treatment room and the first treatment field was about 9 min. The time for building the correlation model was 3.2 min. Tracking errors of 0.55 and 0.95 mm (1σ) were observed in PAN/TILT direction and a 2D range of 3.08 mm. A skin dose was determined of 0.08 mGy/image, with a source-to-skin distance of 900 mm and kV exposure of 1 mAs. On average 1.8 mGy/min kV skin dose was observed for 1 Hz monitoring. CONCLUSION: The Vero tracking solution proved to be fully functional and showed performance comparable with other real-time tracking systems.
Authors: Stefan Gerlach; Ivo Kuhlemann; Floris Ernst; Christoph Fürweger; Alexander Schlaefer Journal: Br J Radiol Date: 2017-07-27 Impact factor: 3.039
Authors: Vincent Caillet; Ricky O'Brien; Douglas Moore; Per Poulsen; Tobias Pommer; Emma Colvill; Amit Sawant; Jeremy Booth; Paul Keall Journal: Med Phys Date: 2019-03-04 Impact factor: 4.071
Authors: Stefan Gerlach; Ivo Kuhlemann; Philipp Jauer; Ralf Bruder; Floris Ernst; Christoph Fürweger; Alexander Schlaefer Journal: Int J Comput Assist Radiol Surg Date: 2016-07-12 Impact factor: 2.924
Authors: Charles A Kunos; Jeffrey M Fabien; John P Shanahan; Christine Collen; Thierry Gevaert; Kenneth Poels; Robbe Van den Begin; Benedikt Engels; Mark De Ridder Journal: J Vis Exp Date: 2015-06-07 Impact factor: 1.355
Authors: Jens Wölfelschneider; Tobias Brandt; Sebastian Lettmaier; Rainer Fietkau; Christoph Bert Journal: Biomed Res Int Date: 2014-11-30 Impact factor: 3.411
Authors: Emma Colvill; Jeremy Booth; Simeon Nill; Martin Fast; James Bedford; Uwe Oelfke; Mitsuhiro Nakamura; Per Poulsen; Esben Worm; Rune Hansen; Thomas Ravkilde; Jonas Scherman Rydhög; Tobias Pommer; Per Munck Af Rosenschold; Stephanie Lang; Matthias Guckenberger; Christian Groh; Christian Herrmann; Dirk Verellen; Kenneth Poels; Lei Wang; Michael Hadsell; Thilo Sothmann; Oliver Blanck; Paul Keall Journal: Radiother Oncol Date: 2016-03-22 Impact factor: 6.280